Ernexa Therapeutics, Inc. (ERNA)
1.88
+0.05
(+2.73%)
USD |
NASDAQ |
Nov 06, 16:00
1.85
-0.03
(-1.60%)
After-Hours: 20:00
Ernexa Therapeutics Net Income (TTM) : -12.26M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.26M |
| March 31, 2026 | -11.39M |
| December 31, 2025 | -14.08M |
| September 30, 2025 | -18.34M |
| June 30, 2025 | -43.70M |
| March 31, 2025 | -46.09M |
| December 31, 2024 | -44.54M |
| September 30, 2024 | -44.93M |
| June 30, 2024 | -23.92M |
| March 31, 2024 | -22.90M |
| December 31, 2023 | -21.67M |
| September 30, 2023 | -20.00M |
| June 30, 2023 | -21.73M |
| March 31, 2023 | -20.62M |
| December 31, 2022 | -24.58M |
| September 30, 2022 | -28.04M |
| June 30, 2022 | -106.71M |
| March 31, 2022 | -113.40M |
| December 31, 2021 | -122.54M |
| September 30, 2021 | -136.05M |
| June 30, 2021 | -52.09M |
| March 31, 2021 | -44.03M |
| December 31, 2020 | -26.53M |
| September 30, 2020 | -6.366M |
| June 30, 2020 | -4.697M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.753M |
| December 31, 2019 | -2.047M |
| September 30, 2019 | -0.702M |
| June 30, 2019 | -0.129M |
| March 31, 2019 | -0.163M |
| December 31, 2018 | -0.259M |
| September 30, 2018 | -0.95M |
| June 30, 2018 | -1.356M |
| March 31, 2018 | -1.396M |
| December 31, 2017 | -1.077M |
| September 30, 2017 | -0.897M |
| June 30, 2017 | -1.286M |
| March 31, 2017 | -1.972M |
| December 31, 2016 | -2.923M |
| September 30, 2016 | -3.454M |
| June 30, 2016 | -4.229M |
| March 31, 2016 | -6.004M |
| December 31, 2015 | -7.226M |
| September 30, 2015 | -7.954M |
| June 30, 2015 | -7.921M |
| March 31, 2015 | -6.644M |
| December 31, 2014 | -5.03M |
| September 30, 2014 | -3.663M |
| June 30, 2014 | -2.582M |
| March 31, 2014 | -1.333M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cerenome, Inc. | -26.09M |
| ACADIA Pharmaceuticals, Inc. | 362.23M |
| Alnylam Pharmaceuticals, Inc. | 2.724B |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |